Skip to content
10-Q

Quarterly Report

CalciMedica, Inc. CALC

0000950170-25-071421

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 6, 2025 13.97M sh
Short Term Investments Q1 2025 · Mar 31, 2025 $12.07M
Short Term Investments Q1 2025 · Dec 31, 2024 $10.73M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $12.56M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $7.94M
Current Liabilities Q1 2025 · Mar 31, 2025 $4.46M
Current Liabilities Q1 2025 · Dec 31, 2024 $3.68M
Total Liabilities Q1 2025 · Mar 31, 2025 $14.46M
Total Liabilities Q1 2025 · Dec 31, 2024 $5.38M
Current Assets Q1 2025 · Mar 31, 2025 $25.22M
Current Assets Q1 2025 · Dec 31, 2024 $19.67M
Total Assets Q1 2025 · Mar 31, 2025 $25.35M
Total Assets Q1 2025 · Dec 31, 2024 $19.79M
Shares Diluted Q1 2025 · Mar 31, 2024 10.05M sh
Capex Q1 2025 · Mar 31, 2024 $0
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$4.72M
Stockholders Equity Q1 2025 · Mar 31, 2024 $17.25M
Stockholders Equity Q1 2025 · Dec 31, 2023 $8.16M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.01
Eps Basic Q1 2025 · Mar 31, 2024 $0.01
Sga Expense Q1 2025 · Mar 31, 2024 $2.82M
Rd Expense Q1 2025 · Mar 31, 2024 $2.94M
Net Income Q1 2025 · Mar 31, 2024 $130K
Operating Income Q1 2025 · Mar 31, 2024 −$5.77M